Precision Medicine & Functional Genomics 2022 (PMFG 2022)

Dates: December 2022
Venue: Doha, Qatar
Format: In-person
CME/CPD: Accredited Group Learning Activity

Overview

Precision Medicine & Functional Genomics 2022 (PMFG 2022) continued Sidra Medicine’s flagship scientific conference series dedicated to advancing genomics and translational research in the region. The conference brought together international experts, clinicians, researchers, and policymakers to examine the evolving role of genomic science in improving diagnosis, treatment, and prevention strategies.

PMFG 2022 focused on accelerating the integration of genomic discoveries into clinical practice. Through multidisciplinary scientific exchange, the conference highlighted advances in rare disease diagnostics, population genomics, therapeutic innovation, and computational biology, reinforcing Sidra Medicine’s leadership in precision medicine for women and children.

Conference Themes

PMFG 2022 explored key areas central to the advancement of precision medicine:

• Population Genomics & Screening – Advancing national genome initiatives and early detection programs.
• Rare Disease & Gene Discovery – Translating genomic insights into improved diagnostic pathways.
• Functional Genomics – Understanding disease mechanisms through experimental and computational approaches.
• Innovative Therapeutics – Progress in gene therapy, targeted treatments, and personalized interventions.
• Data Science & AI in Healthcare – Integrating large-scale genomic data into predictive and clinical decision-making frameworks.

These themes reflected Sidra Medicine’s ongoing commitment to bridging research excellence with real-world healthcare delivery.

Program Highlights

PMFG 2022 featured plenary lectures, thematic scientific sessions, and interactive discussions designed to foster collaboration across disciplines.

Plenary Lectures

Internationally recognized leaders in genomics and translational medicine shared insights into large-scale genome programs, clinical implementation strategies, and therapeutic breakthroughs.

Scientific Sessions

Dedicated sessions addressed:

• Advances in genomic newborn and population screening
• Rare and undiagnosed disease programs
• Multi-omics technologies and biomarker discovery
• Precision oncology and targeted therapies
• Ethical and regulatory frameworks guiding genomic medicine

Collaborative Dialogue

The conference encouraged interdisciplinary exchange between clinicians, laboratory scientists, bioinformaticians, and policymakers, strengthening integration across the precision medicine ecosystem.

Distinguished Speakers

PMFG 2022 welcomed prominent experts from leading global institutions who presented cutting-edge research in genomic medicine, computational biology, and therapeutic development. Sidra Medicine faculty and national collaborators showcased research progress emerging from Qatar’s expanding precision medicine initiatives, including genomic screening programs and translational research platforms.

Learning Objectives & Accreditation

At the conclusion of PMFG 2022, participants were able to:

• Discuss advancements in population genomics and screening initiatives.
• Evaluate emerging approaches in rare disease diagnostics and gene discovery.
• Describe functional genomics strategies for understanding disease mechanisms.
• Identify therapeutic innovations including gene-based and targeted therapies.
• Examine the role of data science and artificial intelligence in precision medicine.

The conference was accredited as a Group Learning Activity and provided continuing medical education credits in accordance with national accreditation standards.

Scientific Impact

PMFG 2022 strengthened Qatar’s role as a regional center of excellence in genomic medicine by fostering international collaboration and multidisciplinary scientific engagement. The conference supported knowledge exchange across academia and healthcare systems, contributing to the advancement of precision diagnostics and personalized therapeutic strategies.

Through continued collaboration and innovation, PMFG 2022 reinforced Sidra Medicine’s mission to integrate genomics into routine clinical care and improve health outcomes across the region.